Our focus is to see that we are growing faster than the industry and, whichever product we launch, we do better than competition. We try and manage our operations better than competition. Essentially, we try to be better than what we were the previous year.

Dilip Shanghvi

Categorized in : See Better Focus Competition

Following the mutual decision to withdraw these plans, the payment bank license will not be pursued.

Dilip Shanghvi

healthcare

Whether the remediation commitments we made are adequate, whether we need to do more ... these are issues we need to assess and understand and probably consult with additional subject matter experts.

Dilip Shanghvi

company-news

Getting the site back in compliance is a major priority and focus.

Dilip Shanghvi

company-news

The Ranbaxy merger has taken more time than originally envisaged.

Dilip Shanghvi

healthcare

I have never seen myself as a promoter. I always evaluate myself as a manager.

Dilip Shanghvi

manager never myself always

If a company is not doing well, it doesn't necessarily mean that it is not a good company.

Dilip Shanghvi

doing good good-company company

Analysts estimate that emerging markets are expected to drive 90 percent of the world's pharmaceutical market growth, and differentiated products will be important to this growth.

Dilip Shanghvi

drive growth important world

Whenever you look at any potential merger or acquisition, you look at the potential to create value for your shareholders.

Dilip Shanghvi

value your look you

Generally, we have competed with ourselves... because I feel that if I compete against somebody, it causes stress. I don't want the process of growth to be stressful.

Dilip Shanghvi

feel growth stress want

I like to win without fighting. But if I can't, then I'm prepared to fight.

Dilip Shanghvi

fight win like fighting

Personally, I feel that a company which looks at problems of other companies and learns from their mistakes is a successful one.

Dilip Shanghvi

mistakes problems feel looks

I have targets for business achievements; I do not have targets for acquisitions. Because if you have targets for acquisitions, you end up making compromises in terms of valuations, and you buy things because you have a target, and it is not good for business.

Dilip Shanghvi

end good you business

Clearly in my mind, I have two distinct positions - owner and manager. So I am open to reviewing my performance as a manager as any other person in Sun Pharma.

Dilip Shanghvi

i-am performance mind sun

The Ranbaxy acquisition doesn't preclude us from making more large acquisitions. The important issue is whether we have the management bandwidth to handle the acquisition.

Dilip Shanghvi

us more important management

The reason we don't give a date by which we will acquire something is because we don't want to create pressure on ourselves to buy something.

Dilip Shanghvi

will pressure reason want

After watching Taro reach the brink of bankruptcy, seeing their shares delisted from trading, hearing endless false promises about receiving audited financial statements, and witnessing an unchecked drain of company resources, the shareholders have clearly had enough.

Dilip Shanghvi

promises reach company enough

A board of directors that cannot produce reliable audited financial statements for almost seven years simply should not remain in office.

Dilip Shanghvi

cannot financial office years

There is no sense in getting excited by market cap because it is a tool.

Dilip Shanghvi

no-sense cap sense excited

Taro will continue to exist as an independent company.

Dilip Shanghvi

continue will company independent

Innovation requires a novel approach to scientific problem solving, higher level of resource commitments over much longer time durations.

Dilip Shanghvi

over innovation problem time